Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-19

FDA Approved: PALONOSETRON — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's original application for Palonosetron, a generic antiemetic, for the prevention of chemotherapy- and postoperative-induce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron (palonosetron)

Snippet

ORIG AP for PALONOSETRON (PALONOSETRON)